Close Menu

It's been four years and the California Institute of Regenerative Medicine is barely off the ground. In June, its newest director, Alan Trounson, allotted $23 million in funding for research on human embryonic stem cells as well as iPS adult stem cell lines, according to the Wall Street Journal. Next, Trounson will fund teams to focus on specific diseases and he hopes to take those therapies to clinical trials within five years.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.